Search results
12 sie 2024 · Parexel and Palantir announced a multi-year strategic partnership to leverage artificial intelligence to help enhance and accelerate the delivery of safe and effective clinical trials for the world’s biopharmaceutical customers.
9 paź 2024 · Parexel releases report on advancing precision oncology. Read more. May 23, 2024. Making the case for fair compensation in clinical trials. Read more. May 1, 2024. As AI proliferates in pharma, regulators look to catch up in clinical trials. Read more. April 29, 2024.
2 lip 2021 · BOSTON and DURHAM, N.C., July 02, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to...
2 lip 2021 · BOSTON and Durham, N.C. July 2, 2021 — Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance patient health, today announced the execution of a definitive merger agreement under which it will be acquired by EQT IX fund (“EQT Private Equity”) and the ...
2 lip 2021 · EQT Private Equity and Goldman Sachs Asset Management to acquire Parexel, a leading global clinical research organization, for USD 8.5 billion.
8 lip 2021 · North Carolina-based clinical research organization (CRO) Parexel has announced the execution of a definitive merger agreement, under which the company will be purchased by EQT Private Equity and Goldman Sachs for $8.5b USD.
2 lip 2021 · Four years after a private equity acquisition took Parexel private, the contract research organization is being acquired by two private equity firms for $8.5 billion. It’s the latest in a series...
